Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients

References

• Marchetti O, Bille J, Fluckiger Uet al.Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991–2000. Clin Infect Dis 2004;38: 311–320.
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Bischoff T, Tallent SMet al.Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39: 309–317.
   PubMed Web of Science ®Google Scholar
• Magill SS, Edwards JR, Bamberg Wet al.Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014;370: 1198–1208.
   PubMed Web of Science ®Google Scholar
• Hsueh PR, Teng LJ, Yang PCet al.Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole. Microb Drug Resist 2002;8: 311–319.
   PubMed Web of Science ®Google Scholar
• Yang ZT, Wu L, Liu XYet al.Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in Shanghai. BMC Infect Dis 2014;14: 241.
   PubMed Web of Science ®Google Scholar
• Tang HJ, Liu WL, Lin HLet al.Epidemiology and prognostic factors of candidemia in cancer patients. PLoS One 2014;9: e99103.
   PubMed Web of Science ®Google Scholar
• Hii IM, Chang HL, Lin LCet al.Changing epidemiology of candidemia in a medical center in middle Taiwan. J Microbiol Immunol Infect 2015;48: 306–315.
   PubMedGoogle Scholar
• Cleveland AA, Harrison LH, Farley MMet al.Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillance. PLoS One 2015;10: e0120452.
   PubMed Web of Science ®Google Scholar
• Khatib R, Johnson LB, Fakih MGet al.Current trends in candidemia and species distribution among adults: Candida glabrata surpasses C. albicans in diabetic patients and abdominal sources. Mycoses 2016;59: 781–786.
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Kibbler C, Peman Jet al.Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 2006;27: 359–366.
   PubMed Web of Science ®Google Scholar
• Wey SB, Mori M, Pfaller MAet al.Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 1988;148: 2642–2645.
   PubMed Web of Science ®Google Scholar
• Zaoutis TE, Argon J, Chu Jet al.The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005;41: 1232–1239.
   PubMed Web of Science ®Google Scholar
• Sipsas NV, Lewis RE, Tarrand Jet al.Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 2009;115: 4745–4752.
   PubMed Web of Science ®Google Scholar
• Slavin MA, Sorrell TC, Marriott Det al.Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death. J Antimicrob Chemother 2010;65: 1042–1051.
   PubMed Web of Science ®Google Scholar
• Chen CY, Huang SY, Tsay Wet al.Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001–2010. Int J Antimicrob Agents 2012;40: 533–538.
   PubMed Web of Science ®Google Scholar
• Puig-Asensio M, Ruiz-Camps I, Fernandez-Ruiz Met al.Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain. Clin Microbiol Infect 2015;21: 491.e1–10.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Righi E, Costa Aet al.Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 2006;6: 21.
   PubMed Web of Science ®Google Scholar
• Hachem R, Hanna H, Kontoyiannis Det al.The changing epidemiology of invasive candidiasis: Candida glabrata and Candida kruseias the leading causes of candidemia in hematologic malignancy. Cancer 2008;112: 2493–2499.
   PubMed Web of Science ®Google Scholar
• Horn DL, Neofytos D, Anaissie EJet al.Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009;48: 1695–1703.
   PubMed Web of Science ®Google Scholar
• Chen LY, Kuo SC, Wu HSet al.Associated clinical characteristics of patients with candidemia among different Candida species. J Microbiol Immunol Infect 2013;46: 463–468.
   PubMedGoogle Scholar
• Horan TC, Andrus M, Dudeck MA.CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36: 309–332.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. (Approved Standard M27-S4), 4th edn.Wayne, PA, USA: National Committee for Clinical and Laboratory Standards.2012.
   Google Scholar
• Sabino R, Verissimo C, Brandao Jet al.Epidemiology of candidemia in oncology patients: a 6-year survey in a Portuguese central hospital. Med Mycol 2010;48: 346–354.
   PubMed Web of Science ®Google Scholar
• Chen PY, Chuang YC, Wang JTet al.Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010. J Microbiol Immunol Infect 2014;47: 95–103.
   PubMedGoogle Scholar
• Tsai CC, Wang CC, Kuo HYet al.Adult candidemia at a medical center in northern Taiwan: a retrospective study. J Microbiol Immunol Infect 2008;41: 414–421.
   PubMedGoogle Scholar
• Chen LY, Liao SY, Kuo SCet al.Changes in the incidence of candidaemia during 2000–2008 in a tertiary medical centre in northern Taiwan. J Hosp Infect 2011;78: 50–53.
   PubMed Web of Science ®Google Scholar
• Chi HW, Yang YS, Shang STet al.Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome. J Microbiol Immunol Infect 2011;44: 369–375.
   PubMedGoogle Scholar
• Ruan SY, Chu CC, Hsueh PR.In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates. Antimicrob Agents Chemother 2008;52: 2919–2922.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Gibbs DLet al.Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 2007;45: 1735–1745.
   PubMed Web of Science ®Google Scholar
• Tan TY, Hsu LY, Alejandria MMet al.Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region. Med Mycol 2016;54: 471–477.
   PubMed Web of Science ®Google Scholar
• Chen YC, Kuo SF, Chen FJet al.Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007–2012: impact of new antifungal breakpoints. Mycoses 2017;60: 89–95.
   PubMed Web of Science ®Google Scholar